AstraZeneca Statistics Share Statistics AstraZeneca has 3.1B
shares outstanding. The number of shares has increased by 99.99%
in one year.
Shares Outstanding 3.1B Shares Change (YoY) 99.99% Shares Change (QoQ) 99.95% Owned by Institutions (%) 16.29% Shares Floating 3.1B Failed to Deliver (FTD) Shares 11 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 6.25M, so 0.2% of the outstanding
shares have been sold short.
Short Interest 6.25M Short % of Shares Out 0.2% Short % of Float 0.2% Short Ratio (days to cover) 1.47
Valuation Ratios The PE ratio is 28.87 and the forward
PE ratio is 14.29.
AstraZeneca's PEG ratio is
1.51.
PE Ratio 28.87 Forward PE 14.29 PS Ratio 3.76 Forward PS 3.7 PB Ratio 4.98 P/FCF Ratio 27.92 PEG Ratio 1.51
Financial Ratio History Enterprise Valuation AstraZeneca has an Enterprise Value (EV) of 126.18B.
EV / Sales 2.33 EV / EBITDA 8.17 EV / EBIT 10.64 EV / FCF 17.34
Financial Position The company has a current ratio of 0.93,
with a Debt / Equity ratio of 0.74.
Current Ratio 0.93 Quick Ratio 0.74 Debt / Equity 0.74 Debt / EBITDA 1.95 Debt / FCF 4.14 Interest Coverage 5.95
Financial Efficiency Return on Equity is 17.25% and Return on Invested Capital is 10.3%.
Return on Equity 17.25% Return on Assets 6.76% Return on Invested Capital 10.3% Revenue Per Employee $573.41K Profits Per Employee $74.6K Employee Count 94,300 Asset Turnover 0.52 Inventory Turnover 1.93
Taxes Income Tax 1.65B Effective Tax Rate 18.99%
Stock Price Statistics The stock price has increased by -10.22% in the
last 52 weeks. The beta is 0.15, so AstraZeneca's
price volatility has been higher than the market average.
Beta 0.15 52-Week Price Change -10.22% 50-Day Moving Average 71.92 200-Day Moving Average 70.45 Relative Strength Index (RSI) 53.41 Average Volume (20 Days) 4,684,217
Income Statement In the last 12 months, AstraZeneca had revenue of 54.07B
and earned 7.04B
in profits. Earnings per share was 2.27.
Revenue 54.07B Gross Profit 43.87B Operating Income 10B Net Income 7.04B EBITDA 15.44B EBIT 10.43B Earnings Per Share (EPS) 2.27
Full Income Statement Balance Sheet The company has 5.49B in cash and 30.11B in
debt, giving a net cash position of -24.63B.
Cash & Cash Equivalents 5.49B Total Debt 30.11B Net Cash -24.63B Retained Earnings 3.16B Total Assets 112.42B Working Capital -4.6B
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 11.86B
and capital expenditures -4.59B, giving a free cash flow of 7.28B.
Operating Cash Flow 11.86B Capital Expenditures -4.59B Free Cash Flow 7.28B FCF Per Share 2.35
Full Cash Flow Statement Margins Gross margin is 81.12%, with operating and profit margins of 18.5% and 13.01%.
Gross Margin 81.12% Operating Margin 18.5% Pretax Margin 16.07% Profit Margin 13.01% EBITDA Margin 28.55% EBIT Margin 18.5% FCF Margin 13.45%
Dividends & Yields AZN pays an annual dividend of $2.05,
which amounts to a dividend yield of 2.13%.
Dividend Per Share $2.05 Dividend Yield 2.13% Dividend Growth (YoY) 6.6% Payout Ratio 77.26% Earnings Yield 3.46% FCF Yield 7.16%
Dividend Details Analyst Forecast The average price target for AZN is $95,
which is 28.2% higher than the current price. The consensus rating is "Buy".
Price Target $95 Price Target Difference 28.2% Analyst Consensus Buy Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $30.01 Lynch Upside -59.5% Graham Number 51.84 Graham Upside -30.03%
Stock Splits The last stock split was on Jul 27, 2015. It was a
forward
split with a ratio of 2:1.
Last Split Date Jul 27, 2015 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 2.91 Piotroski F-Score 7
